NCT07286318 2026-02-19
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
Phase EARLY_PHASE1 Not yet recruiting
University of Pittsburgh
Ohio State University Comprehensive Cancer Center
CivaTech Oncology
Center for Biomedical Research, Inc.
Johns Hopkins University
Bispebjerg Hospital
Stanford University
The Cleveland Clinic